Pila Pharma AB (publ) (STO:PILA)
Sweden · Delayed Price · Currency is SEK 1.535
+0.125 (8.87%)
Nov 3, 2026, 5:25 PM CET
Pila Pharma AB Market Cap
Pila Pharma AB has a market cap or net worth of 70.12 million as of November 3, 2026. It is the 43,172nd most valuable company in the world and the 637th biggest in Sweden. Its market cap has decreased by 23.22% in one year.
Market Cap
70.12M
Enterprise Value
66.87M
Revenue
275.74K
Global Rank
Country Rank
#637 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2021, Pila Pharma AB's market cap has decreased from 144.39M to 70.12M, a decrease of -51.43%. That is a compound annual growth rate of -12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 70.12M | -19.12% |
| Dec 30, 2025 | 86.69M | -14.78% |
| Dec 30, 2024 | 101.72M | 167.21% |
| Dec 29, 2023 | 38.07M | -23.60% |
| Dec 29, 2022 | 49.83M | -54.49% |
| Dec 30, 2021 | 109.48M | -24.17% |
| Jul 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 139.73M |
| Xintela AB | 134.36M |
| Initiator Pharma | 133.14M |
| Alzinova AB | 112.04M |
| Active Biotech AB | 105.31M |
| OncoZenge AB | 85.84M |
| Ascelia Pharma AB | 77.45M |
| AcouSort AB | 68.15M |